Ranok Therapeutics (hangzhou) Co., Ltd.
Clinical trials sponsored by Ranok Therapeutics (hangzhou) Co., Ltd., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New targeted pill takes on Hard-to-Treat pancreatic cancer Results expected Nov 2026 (estimated)
- New drug targets Hard-to-Treat cancer mutation in early trial Results expected Dec 2026 (estimated)
- Healthy volunteers needed to test how food changes drug absorption Results expected Dec 2026 (estimated)